Author(s):
Shalu Verma, Alka Singh, Vikash Jakhmola
Email(s):
vermashalu339@gmail.com
DOI:
10.52711/0974-360X.2023.00202 
Address:
Shalu Verma1*, Alka Singh2, Vikash Jakhmola3
1Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand - 248007, India.
2School of Pharmaceutical Sciences and Technology, Sardar Bhagwan Singh University, Dehradun, Uttarakhand - 248161, India.
3Uttaranchal Institute of Pharmaceutical Sciences, Uttarakhand, Dehradun-248007, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2023
ABSTRACT:
The goal of this work was to create Spiranolactone-loaded ethosomes and use them as a topical acne therapy gel. The size of the vesicle, Spiranolactone filling, and encapsulation function of ethosomes were all created and tested. Improved ethosomes were produced as Carbomer 974 gels and tested for transdermal permeability and porosity, as well as in vitro transplantation, against traditional hydroethanolic gels. With Spiranolactone efficiency of loading and encapsulation of 0.433±0.006 mg/mL and 39.29±0.65 percent, the produced ethosomes had a mean size of vesicle 68.1±1.8 nm. A well-developed ethosomal gel had 2.5 times the transdermal flux and 2.1 times the skin implantation of regular gels. For mild skin irritation, ethosomal gel has a superior anti-acne impact. This research reveals that ethosomal formation is a good way to transfer spiranolactone to the skin, and that spiranolactone ethosomal gels could be used to treat acne in the future.
Cite this article:
Shalu Verma, Alka Singh, Vikash Jakhmola. Ethosomes Loaded with Spiranolactone for Acne treatment through Topical Gel Formulation. Research Journal of Pharmacy and Technology 2023; 16(3):1219-4. doi: 10.52711/0974-360X.2023.00202
Cite(Electronic):
Shalu Verma, Alka Singh, Vikash Jakhmola. Ethosomes Loaded with Spiranolactone for Acne treatment through Topical Gel Formulation. Research Journal of Pharmacy and Technology 2023; 16(3):1219-4. doi: 10.52711/0974-360X.2023.00202 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-3-38
REFRENCES:
1. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem. 2011; 44(13): 1035–40. doi: 10.1016/ j.clinbiochem. 2011.06.984
2. Bloom DF. Is acne really a disease?: a theory of acne as an evolutionarily significant, high-order psychoneuroimmune interaction timed to cortical development with a crucial role in mate choice. Med Hypotheses. 2004; 62(3): 462–469. doi: 10.1016/j.mehy.2003.11.003
3. Liu PF, Hsieh YD, Lin YC, Two A, Shu CW, Huang CM. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris. Curr Drug Metab. 2015; 16(4): 245–254. doi: 10.2174/1389200216666150812124801
4. Valente DS IC. Novel pharmacological approaches for the treatment of acne vulgaris. Expert Opin Investig Drugs. 2014; 23(10): 1389–410. doi: 10.1517/13543784.2014.923401
5. Cai Y, Zhang W, Chen Z, Shi Z, He C, ChenM. Recent insights into the biological activities and drug delivery systems of tanshinones. Int J Nanomedicine. 2016; 11: 121–30. doi:10.2147/ ijn.s84035
6. Tang S, Shen XY, Huang HQ, Xu SW, Yu Y, Zhou CH. Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-kappaB and MAPK signalling pathways. Inflammation. 2011; 34(2): 111–118. doi: 10.1007/s10753-010-9214-3
7. Wu CY, Hsieh CY, Huang KE, Chang C, Kang HY. Cryptotanshinone down-regulates androgen receptor signaling by modulating lysine-specific demethylase 1 function. Int J Cancer. 2012; 131: 1423–34
8. Akhtar N. Vesicles: a recently developed novel carrier for enhanced topical drug delivery. Curr Drug Deliv. 2014; 11(1): 87–97. doi: 10.2174/15672018113106660064
9. Sneh Priya, Divya Jyothi, Jainey P James, Amala Maxwell. Formulation and Optimization of Ethosomes loaded with Ropinirole Hydrochloride: Application of quality by Design Approach. Research J. Pharm. and Tech, 2020; 13(9): 4339-4345. doi:10.5958/0974-360x.2020.00767.2
10. Baek JS, Pham CV, Myung CS, Cho CW. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Int J Pharm. 2015; 495(2): 701–9. doi: 10.1016/j.ijpharm.2015.09.054
11. Ashok A. Hajare, Hemalata S. Dol. Screening of effective formulation techniques for Designing and Fabrication of Terbinafine hydrochloride ethosomes. Research J. Pharm. and Tech. 2021; 14(3): 1353-1359. doi:10.5958/0974-360x.2021.00241.9
12. Monisha C, GNK. Ganesh, Mythili L, Kayalvizhi Radhakrishnan. A Review on Ethosomes for Transdermal Application. Research J. Pharm. and Tech. 2019; 12(7): 3133-3143. doi: 10.5958/0974-360x.2019.00529.8
13. Moghal. Roohi Shabreen, S. Sangeetha. Ethosomes: A Novel Drug Delivery System And Their Therapeutic Applications -A Review. Research J. Pharm. and Tech, 2020; 13(4): 1970-1978.
14. OECD. Test No. 404: Acute Dermal Irritation/Corrosion, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. 2015.
15. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm., 2003; 258(1-2):141–151. doi: 10.1016/s0378-5173(03)00183-2
16. Shraddha Pandey, Shashi Kiran Misra, Nisha Sharma. Ethosomes- A Novelize Vesicular Drug Delivery System. Research J. Pharm. and Tech., 2017; 10(9): 3223-3232. doi: 10.5958/0974-360x.2017.00572.8
17. Amala Maxwell, Sneh Priya. Nanosized Ethosomes – A Promising Vesicular Drug Carrier for Transdermal Drug Delivery. Research J. Pharm. and Tech., 2019; 12(2): 876-880. doi: 10.5958/0974-360x.2019.00150.1
18. Dubey V, Mishra D, Jain NK. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 2007; 67(2): 398–405. doi: 10.1016/j.ejpb.2007.03.007
19. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 2006; 322(1-2): 60–6. doi: 10.1016/j.ijpharm.2006.05.027
20. Choi EH, Ahn SK, Lee SH. The changes of stratum corneum interstices and calcium distribution of follicular epithelium of experimentally induced comedones (EIC) by oleic acid. Exp Dermatol. 1997; 6(1): 29–35. doi: 10.1111/j.1600-0625.1997.tb00142.x
21. Yamakoshi T, Makino T, Matsunaga K, Yoshihisa Y, Rehman MU, Seki T. Efficacy of chlorhexidine gluconate ointment (Oronine H((R))) for experimentally-induced comedones. Clin Cosmet Investig Dermatol. 2012; 5: 79–83. doi: 10.2147/ccid.s33361
22. Kwon HH, Lee JB, Yoon JY, Park SY, Ryu HH, Park BM. The clinical and histological effect of homeuse, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial. Br J Dermatol. 2013; 168: 1088–94.
23. R.B. Saudagar, S. Samuel. Ethosomes: Novel noninvasive carrier for Transdermal Drug Delivery. Asian J. Pharm. Tech. 2016; 6(2): 135-138. doi: 10.5958/2231-5713.2016.00019.2
24. Roge Ashish B, Sakhare Ram S, Bakal RL, Channawar MA, Bakde BV, Gawande SR , Chandewar AV. Ethosomes: Novel Approach in Transdermal Drug Delivery System. Research J. Pharma. Dosage Forms and Tech. 2010; 2(1): 23-27.
25. Anuradha Patel, R.K. Sharma, Mahesh Trivedi, Shivaprakash, Anjana Panicker. Ethosomes: A Novel Tool for Transdermal Drug Delivery. Research J. Pharm. and Tech. 2013; 6(8): 838-841.